Trueblood Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Trueblood Wealth Management, LLC holds 14 biotech & pharma companies tracked by BioSniper, totaling $10.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$10.4M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 9,619 | $2.1M |
| JNJJOHNSON & JOHNSON | 7,981 | $2.0M |
| LNTHLantheus Holdings, Inc. | 11,043 | $838K |
| MRKMerck & Co., Inc. | 6,591 | $793K |
| LLYELI LILLY & Co | 833 | $766K |
| ELVElevance Health Inc. | 2,382 | $697K |
| ABTABBOTT LABORATORIES | 6,662 | $684K |
| GILDGILEAD SCIENCES, INC. | 4,377 | $610K |
| CATXPerspective Therapeutics, Inc. | 99,061 | $413K |
| PMPhilip Morris International Inc | 2,454 | $406K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,469 | $397K |
| ZTSZoetis Inc. | 3,128 | $370K |
| AMGNAMGEN INC | 666 | $234K |
| ATAIAtai Beckley N.V. | 50,000 | $177K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.